Figure 5.
The efficacy of oxaliplatin-based treatment was positively correlated with FA pathway mutations, while negatively correlated with MMR pathway mutations. The correlations were both significant.
The efficacy of oxaliplatin-based treatment was positively correlated with FA pathway mutations, while negatively correlated with MMR pathway mutations. The correlations were both significant.